Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Revenue (2019 - 2025)

Silo Pharma (SILO) has disclosed Revenue for 7 consecutive years, with $18026.0 as the latest value for Q4 2025.

  • Quarterly Revenue changed 0.0% to $18026.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72102.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $72102.0 for FY2025, 0.0% changed from the prior year.
  • Revenue hit $18026.0 in Q4 2025 for Silo Pharma, roughly flat from $18025.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $86148.0 in Q1 2022 to a low of -$483.0 in Q3 2021.
  • Historically, Revenue has averaged $23570.0 across 5 years, with a median of $18025.5 in 2022.
  • Biggest YoY gain for Revenue was 16033.67% in 2021; the steepest drop was 102.97% in 2021.
  • Year by year, Revenue stood at -$164.0 in 2021, then surged by 11091.46% to $18026.0 in 2022, then changed by 0.0% to $18026.0 in 2023, then changed by 0.0% to $18026.0 in 2024, then changed by 0.0% to $18026.0 in 2025.
  • Business Quant data shows Revenue for SILO at $18026.0 in Q4 2025, $18025.0 in Q3 2025, and $18025.0 in Q2 2025.